Navigation Links
CRO Acquisition Seen Boosting Activity, Positioning ASG, Inc., for New Growth in Q2
Date:5/5/2009

CARY, N.C., May 5 /PRNewswire/ -- ASG, Inc., saw continued growth in the first quarter following its acquisition of neighboring Ockham Development Group.

The February merger with the full-service contract research organization sought to expand the breadth and value of services that Cary, North Carolina-based ASG provides clients requiring functional outsourcing and staffing services or the opportunity to outsource an entire clinical trial.

ASG's CEO Jim Baker said, "I am pleased to announce that we continue to make progress in merging the two companies into one."

Through Ockham, ASG has secured new work in the therapeutic areas of oncology, anti-infectives, and vaccines. Ockham has picked up some "significant new business in the last month, and the emerging-growth biotech and pharma market seems to be picking up steam as we move into Q2," Baker said.

In the meantime, Baker indicated that ASG is "answering more functional outsourcing RFPs" and has recently won outsourcing work with one of the company's larger clients.

He also noted a staffing headcount increase over the past 45 days.

In completing the acquisition, ASG's global growth strategy will allow the firm to provide solutions that best meet the needs of existing and potential clients. At the same time, the acquisition will make it possible for Ockham - which will continue to be independently branded - to serve a wider and larger client base.

About ASG:

ASG is a global clinical research service provider of high-quality Contract Research, Functional Outsourcing, and Specialty Staffing services to CROs, pharmaceutical, biotech and medical device companies that require clinical operations, GCP, GLP or GMP auditing, data management, statistical programming, biostatistics and medical writing solutions. Strategically organized to meet the demands of the marketplace, A
'/>"/>

SOURCE ASG, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
4. NxStage Medical Provides Update on Medisystems Acquisition
5. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
6. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
7. Federal Trade Commission Clears Kyphons Acquisition of Non-Vertebroplasty Spine-Related Assets of Disc-O-Tech
8. Shanghai Century Acquisition Corporation Announces Sichuan Kelun Pharmaceutical Co Results for the Six Months Ended June 30, 2007
9. Advanced Bio-Technologies Inc Announces Acquisition by HealthEdge Investment Partners, Tampa FL
10. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
11. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... CA (PRWEB) June 18, 2013 (PRWEB) June 18, ... #1 time and attendance system in North America, ... that shares employee data and payroll records between ... AccountLinx Plus automates ExakTime software setup and ... software imports employee data from a business’ current ...
(Date:6/18/2013)... Phoenix, AZ (PRWEB) June 18, 2013 ... the 2013 Innovation Challenge Winner out of hundreds of ... in its spring Arizona Innovation Challenge . The ... the country for a technology commercialization challenge, granting a ... world’s most promising technology ventures. Nasseo’s state of the ...
(Date:6/18/2013)...  AMRI (NASDAQ: AMRI ) announced ... , site has received approval to expand its ... handle Schedule 2 and 2N controlled substances. The ... Burlington,s physical security and quality systems, ... http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) With its ...
(Date:6/18/2013)... , June 18, 2013 ... has announced the addition of the report ... Companies " to their offering. ... briefly reviews basics of human genome variations, ... Current large and small sequencers are described ...
Breaking Biology Technology:ExakTime Introduces AccountLinx Plus 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2
... Cardium Therapeutics (NYSE Amex: CXM ) today ... the U.S. Food and Drug Administration (FDA) seeking marketing ... Excellagen XL is an advanced wound care management ... designed for use by physicians in patients with topical ...
... DUBLIN, Ireland, November 2 The Board of,Directors of ... Mr David,Stout joined the Board as a Non Executive Director ... Mr Stout has extensive pharmaceutical experience. Most recently he was,President, ... pharmaceutical operations in the United States, Europe,Japan and all other ...
... successful phase III trial points to the first new lupus ... 2 The Lupus Research Institute (LRI) and its National ... Sciences (HGS) and GlaxoSmithKline for achieving an historical landmark - ... the first successfully tested new drug developed specifically for people ...
Cached Biology Technology:Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds 2Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds 3Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds 4New Shire Board Member 2Lupus Research Institute: Benlysta(TM) Trial Results in an Historic Research Breakthrough and Victory for People With Lupus 2
(Date:6/17/2013)... foundations with more modern elements. Using this same approachbut ... Dietrich School of Arts and Sciences have designed a ... storage, and gas transport more efficient and at a ... issue of the Journal of the American Chemical ... builds upon Pitt Associate Professor of Chemistry Nathaniel Rosi,s ...
(Date:6/17/2013)... The AGA Research Foundation and Horizon Pharma further ... gastroenterology with the 2013 AGA-Horizon Pharma Fellow Abstract Prizes ... "In its third year, this competition continues to grow ... promising careers in basic and clinical research," said Nicholas ... Foundation. "We are extremely proud of all that these ...
(Date:6/16/2013)... programs for female sex workers in India reduce rates ... a University of Toronto study has found. ... mostly in the southern states of Andhra Pradesh, Karnataka, ... Prabhat Jha from U of T,s Dalla Lana School ... Global Health Research (CGHR), examined the impact of prevention ...
Breaking Biology News(10 mins):'Chemical architects' build materials with potential applications in drug delivery and gas storage 2Horizon Pharma Abstract Prizes recognize promising fellows and students 2HIV prevention among female sex workers in India reduces HIV and syphilis 2
... and the environment will gather in Nairobi, Kenya this ... cycle of drought and food insecurity. The Beating Famine ... the Sahel region of Africa, this time through Niger, ... will take place on April 10-13 at the World ...
... 2012 The Canadian Journal of Cardiology ... Society,s atrial fibrillation guidelines. Atrial fibrillation is the ... stroke, illness in general, and death. It is, for example, ... year has seen important changes in the drugs available to ...
... known for its role in embryonic development and cancer ... or scleroderma, therapy. The finding, discovered by a cross-disciplinary ... Hughes Distinguished Professor of Rheumatology at Northwestern University Feinberg ... Arthritis & Rheumatism. "We showed, for ...
Cached Biology News:Beating famine: Sustainable food security through land regeneration in a changing climate 2New genetic path for scleroderma 2
... 3.1.21.1) is a nonspecific endonuclease that degrades ... by hydrolyzing phosphodiester linkages, producing mono and ... group. Ambion's RNase-free DNase I is of ... to degrade DNA in the presence of ...
Rabbit polyclonal antibody to Neuromedin U Receptor 1 (GPR66)...
... Perhaps sheer in-house demand is causing ... want your precious antibody. This can cause ... • Receive royalties for your hard ... and let us build it up and ...
... (rat) - Diluted Antiserum for RIA, Host: ... U-23 (rat) Immunology Products, Host: Rabbit ... our corresponding peptide and 1 ... Neuromedin U-23 (rat) (H-9295) and ([ 1 ...
Biology Products: